Bacterial resistance and the dental professionals' role to halt the problem

Journal of Dentistry

Volumn 36, Issue 2, 2008, Pages 95-103

  Al Haroni, Mohammed ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Antibiotics use; Bacterial resistance; Dentists; Role

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL PHENOMENA AND FUNCTIONS; DENTIST; HUMAN; PHYSIOLOGY; PRESCRIPTION; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIAL PHYSIOLOGY; DENTISTS; DRUG RESISTANCE, BACTERIAL; HUMANS; PRESCRIPTIONS, DRUG;

EID: 38349165316     PISSN: 03005712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdent.2007.11.007     Document Type: Review

References (96)

1. Falagas M.E., and Bliziotis I.A. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?. International Journal of Antimicrobial Agents 29 (2007) 630-636
2. WHO report on infectious diseases. Weekly Epidemiological Record 1999;74:279.
3. Wise R., Hart T., Cars O., Streulens M., Helmuth R., Huovinen P., et al. Antimicrobial resistance. Is a major threat to public health. BMJ 317 (1998) 609-610
4. Sweeney L.C., Dave J., Chambers P.A., and Heritage J. Antibiotic resistance in general dental practice-a cause for concern?. The Journal of Antimicrobial Chemotherapy 53 (2004) 567-576
5. Andersson D. The ways in which bacteria resist antibiotics (background document). Seminar on the Global Threat of Antibiotic Resistance - Exploring Roads Towards Concerted Action (2004)
6. Bebear C.M., and Pereyre S. Mechanisms of drug resistance in Mycoplasma pneumoniae. Current Drug Targets - Infectious Disorders 5 (2005) 263-271
7. Pavicic M.J., van Winkelhoff A.J., Pavivic-Temming Y.A., and de Graaff J. Metronidazole susceptibility factors in Actinobacillus actinomycetemcomitans. The Journal of Antimicrobial Chemotherapy 35 (1995) 263-269
8. Narikawa S. Distribution of metronidazole susceptibility factors in obligate anaerobes. The Journal of Antimicrobial Chemotherapy 18 (1986) 565-574
9. Jain R., Rivera M.C., Moore J.E., and Lake J.A. Horizontal gene transfer in microbial genome evolution. Theoretical Population Biology 61 (2002) 489-495
10. Griffith F. The significance of pneumococcal types. Journal of Hygiene 27 (1928) 113-159
11. Cvitkovitch D.G. Genetic competence and transformation in oral streptococci. Critical Reviews in Oral Biology & Medicine 12 (2001) 217-243
12. Hakenbeck R., and Coyette J. Resistant penicillin-binding proteins. Cellular and Molecular Life Sciences 54 (1998) 332-340
13. Lysogeny L.A. Bacteriological Reviews 17 (1953) 269-337
14. Hewitt L.F. Bacteriophage as a factor in epidemiology and bacterial evolution; lysis of diphtheria Bacilli by Staphylococcal bacteriophage. The Lancet 2 (1952) 272-273
15. Freeman V.J., and Morse I.U. Further observations on the change to virulence of bacteriophage-infected a virulent strains of Corynebacterium diphtheria. Journal of Bacteriology 63 (1952) 407-414
16. Tatum E.L., and Lederberg J. Gene Recombination in the Bacterium Escherichia coli. Journal of Bacteriology 53 (1947) 673-684
17. Moritz E.M., and Hergenrother P.J. The prevalence of plasmids and other mobile genetic elements in clinically important drug-resistant bacteria. In: Amabile-Cuevas C.F. (Ed). Antimicrobial resistance in bacteria (2007), Horizon Bioscience, Wymondham, UK 25-53
18. Dowson C.G., Hutchison A., Woodford N., Johnson A.P., George R.C., and Spratt B.G. Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proceedings of the National Academy of Sciences of the United States of America, 87 (1990) 5858-5862
19. Livermore D.M. beta-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 8 (1995) 557-584
20. Carlier J.P., Sellier N., Rager M.N., and Reysset G. Metabolism of a 5-nitroimidazole in susceptible and resistant isogenic strains of Bacteroides fragilis. Antimicrobial Agents and Chemotherapy 41 (1997) 1495-1499
21. Leclercq R., and Courvalin P. Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrobial Agents and Chemotherapy 35 (1991) 1273-1276
22. Leclercq R., and Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrobial Agents and Chemotherapy 35 (1991) 1267-1272
23. Connell S.R., Tracz D.M., Nierhaus K.H., and Taylor D.E. Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrobial Agents and Chemotherapy 47 (2003) 3675-3681
24. Roberts M.C. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiology Reviews 19 (1996) 1-24
25. Bush K. Classification of beta-lactamases: groups 1, 2a, 2b, and 2b′. Antimicrobial Agents and Chemotherapy 33 (1989) 264-270
26. Bush K. Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4. Antimicrobial Agents and Chemotherapy 33 (1989) 271-276
27. Bush K., Jacoby G.A., and Medeiros A.A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 39 (1995) 1211-1233
28. Ambler RP. The structure of beta-lactamases. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 1980;289:321-31.
29. Pitout J.D., Sanders C.C., and Sanders Jr. W.E. Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. The American Journal of Medicine 103 (1997) 51-59
30. Handal T., and Olsen I. Antimicrobial resistance with focus on oral beta-lactamases. European Journal of Oral Sciences 108 (2000) 163-174
31. Walker C.B., Gordon J.M., and Socransky S.S. Antibiotic susceptibility testing of subgingival plaque samples. Journal of Clinical Periodontology 10 (1983) 422-432
32. Sutter V.L., Jones M.J., and Ghoneim A.T. Antimicrobial susceptibilities of bacteria associated with periodontal disease. Antimicrobial Agents and Chemotherapy 23 (1983) 483-486
33. Valdes M.V., Lobbins P.M., and Slots J. Beta-lactamase producing bacteria in the human oral cavity. Journal of Oral Pathology 11 (1982) 58-63
34. Heimdahl A., von Konow L., and Nord C.E. Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Archives of Oral Biology 25 (1980) 689-692
35. Kinder S.A., Holt S.C., and Korman K.S. Penicillin resistance in the subgingival microbiota associated with adult periodontitis. Journal of Clinical Microbiology 23 (1986) 1127-1133
36. Legg J.A., and Wilson M. The prevalence of beta-lactamase producing bacteria in subgingival plaque and their sensitivity to Augmentin. British Journal of Oral & Maxillofacial Surgery 28 (1990) 180-184
37. Fosse T., Madinier I., Hitzig C., and Charbit Y. Prevalence of beta-lactamase-producing strains among 149 anaerobic gram-negative rods isolated from periodontal pockets. Oral Microbiology and Immunology 14 (1999) 352-357
38. Nyfors S., Kononen E., Takala A., and Jousimies-Somer H. Beta-lactamase production by oral anaerobic gram-negative species in infants in relation to previous antimicrobial therapy. Antimicrobial Agents and Chemotherapy 43 (1999) 1591-1594
39. Kononen E., Nyfors S., Matto J., Asikainen S., and Jousimies-Somer H. beta-lactamase production by oral pigmented Prevotella species isolated from young children. Clinical Infectious Diseases 25 (1997) S272-S274
40. Tuner K., Lindqvist L., and Nord C.E. Purification and properties of a novel beta-lactamase from Fusobacterium nucleatum. Antimicrobial Agents and Chemotherapy 27 (1985) 943-947
41. Kononen E., Kanervo A., Salminen K., and Jousimies-Somer H. beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. Antimicrobial Agents and Chemotherapy 43 (1999) 1270-1273
42. van Winkelhoff A.J., Herrera Gonzales D., Winkel E.G., Dellemijn-Kippuw N., Vandenbroucke-Grauls C.M., and Sanz M. Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis. A comparison between The Netherlands and Spain. Journal of Clinical Periodontology 27 (2000) 79-86
43. Walker C.B. The acquisition of antibiotic resistance in the periodontal microflora. Periodontology 2000 10 (1996) 79-88
44. van Winkelhoff A.J., Winkel E.G., Barendregt D., Dellemijn-Kippuw N., Stijne A., and van der Velden U. beta-Lactamase producing bacteria in adult periodontitis. Journal of Clinical Periodontology 24 (1997) 538-543
45. Nagy E., Szoke I., Gacs M., and Csiszar K. Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains. Acta Microbiologica et Immunologica Hungarica 42 (1995) 287-299
46. Prieto-Prieto J., and Calvo A. Microbiological basis of oral infections and sensitivity to antibiotics. Medicina Oral, Patología Oral y Cirugía Bucal 9 (2004) 15-8; 1-4
47. Lacroix J.M., and Walker C. Characterization of a beta-lactamase found in Eikenella corrodens. Antimicrobial Agents and Chemotherapy 35 (1991) 886-891
48. Lacroix J.M., and Walker C.B. Identification of a streptomycin resistance gene and a partial Tn3 transposon coding for a beta-lactamase in a periodontal strain of Eikenella corrodens. Antimicrobial Agents and Chemotherapy 36 (1992) 740-743
49. Giraud-Morin C., Madinier I., and Fosse T. Sequence analysis of cfxA2-like beta-lactamases in Prevotella species. The Journal of Antimicrobial Chemotherapy 51 (2003) 1293-1296
50. Madinier I.M., Fosse T.B., Hitzig C., Charbit Y., and Hannoun L.R. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans. Journal of Periodontology 70 (1999) 888-892
51. Handal T., Olsen I., Walker C.B., and Caugant D.A. Beta-lactamase production and antimicrobial susceptibility of subgingival bacteria from refractory periodontitis. Oral Microbiology and Immunology 19 (2004) 303-308
52. Handal T., Olsen I., Walker C.B., and Caugant D.A. Detection and characterization of beta-lactamase genes in subgingival bacteria from patients with refractory periodontitis. FEMS Microbiology Letters 242 (2005) 319-324
53. Al-Haroni M., Skaug N., Bakken V., and Cash P. Proteomic analysis of Ampicillin-resistant oral Fusobacterium nucleatum. Oral Microbiology And Immunology 23 (2008) 36-42
54. Levy S.B., and Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nature Medicine 10 (2004) S122-S129
55. Bonten M.J., Slaughter S., Ambergen A.W., Hayden M.K., van Voorhis J., Nathan C., et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Archives of Internal Medicine 158 (1998) 1127-1132
56. Harbarth S., and Samore M.H. Antimicrobial resistance determinants and future control. Emerging Infectious Diseases 11 (2005) 794-801
57. Goossens H., Ferech M., Vander Stichele R., and Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. The Lancet 365 (2005) 579-587
58. Austin DJ, Anderson RM. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. Philosophical Transactions of the Royal Society of London. Series B, Biological sciences 1999;354:721-38.
59. Seppala H., Klaukka T., Vuopio-Varkila J., Muotiala A., Helenius H., Lager K., et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. The New England Journal of Medicine 337 (1997) 441-446
60. Montecalvo M.A., Jarvis W.R., Uman J., Shay D.K., Petrullo C., Rodney K., et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Annals of Internal Medicine 131 (1999) 269-272
61. Nourse C., Byrne C., Murphy H., Kaufmann M.E., Clarke A., and Butler K. Eradication of vancomycin resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children. Epidemiology and Infection 124 (2000) 53-59
62. Courvalin P. Antimicrobial drug resistance: "Prediction Is Very Difficult, Especially about the Future". Emerging Infectious Diseases 11 (2005) 1503-1506
63. Canet J.J., and Garau J. Importance of dose and duration of beta-lactam therapy in nasopharyngeal colonization with resistant pneumococci. The Journal of Antimicrobial Chemotherapy 50 (2002) 39-43
64. Larrabee T. Prescribing practices that promote antibiotic resistance: strategies for change. Journal of Pediatric Nursing 17 (2002) 126-132
65. Cornaglia G., Lonnroth A., and Struelens M. Report from the European Conference on the Role of Research in Combating Antibiotic Resistance, 2003. Clinical Microbiology and Infection 10 (2004) 473-497
66. Macfarlane J., Holmes W., Macfarlane R., and Britten N. Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. BMJ 315 (1997) 1211-1214
67. Buke C., Hosgor-Limoncu M., Ermertcan S., Ciceklioglu M., Tuncel M., Kose T., et al. Irrational use of antibiotics among university students. The Journal of Infection 51 (2005) 135-139
68. Okeke I.N., Klugman K.P., Bhutta Z.A., Duse A.G., Jenkins P., O'Brien T.F., et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. The Lancet Infectious Diseases 5 (2005) 568-580
69. Okeke I.N., Laxminarayan R., Bhutta Z.A., Duse A.G., Jenkins P., O'Brien T.F., et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. The Lancet Infectious Diseases 5 (2005) 481-493
70. Okeke I.N., Lamikanra A., and Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerging Infectious Diseases 5 (1999) 18-27
71. Palmer N.O., Martin M.V., Pealing R., and Ireland R.S. An analysis of antibiotic prescriptions from general dental practitioners in England. The Journal of Antimicrobial Chemotherapy 46 (2000) 1033-1035
72. Standing Medical Advisory Committee. The path of least resistance (1998), Department of Health, London
73. Pallasch T.J. Antibiotic resistance. Dental Clinics of North America 47 (2003) 623-639
74. Al-Haroni M., and Skaug N. Incidence of antibiotic prescribing in dental practice in Norway and its contribution to national consumption. The Journal of Antimicrobial Chemotherapy 59 (2007) 1161-1166
75. Epstein J.B., Chong S., and Le N.D. A survey of antibiotic use in dentistry. Journal of the American Dental Association 131 (2000) 1600-1609
76. Andersson D.I. The biological cost of mutational antibiotic resistance: any practical conclusions?. Current Opinion in Microbiology 9 (2006) 461-465
77. Horcajada J.P., Soto S., Gajewski A., Smithson A., Jimenez de Anta M.T., Mensa J., et al. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. Journal of Clinical Microbiology 43 (2005) 2962-2964
78. Vila J., Simon K., Ruiz J., Horcajada J.P., Velasco M., Barranco M., et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent?. The Journal of Infectious Diseases 186 (2002) 1039-1042
79. Feres M., Haffajee A.D., Allard K., Som S., Goodson J.M., and Socransky S.S. Antibiotic resistance of subgingival species during and after antibiotic therapy. Journal of Clinical Periodontology 29 (2002) 724-735
80. Andersson D.I. Persistence of antibiotic resistant bacteria. Current Opinion in Microbiology 6 (2003) 452-456
81. Nilsson A.I., Zorzet A., Kanth A., Dahlstrom S., Berg O.G., and Andersson D.I. Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes. Proceedings of the National Academy of Sciences of the United States of America, 103 (2006) 6976-6981
82. Cars O., Molstad S., and Melander A. Variation in antibiotic use in the European Union. The Lancet 357 (2001) 1851-1853
83. Theilade E., and Theilade J. Role of plaque in the etiology of periodontal disease and caries. Oral Sciences Reviews 9 (1976) 23-63
84. Sbordone L., and Bortolaia C. Oral microbial biofilms and plaque-related diseases: microbial communities and their role in the shift from oral health to disease. Clinical Oral Investigations 7 (2003) 181-188
85. Slots J., and Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontology 2000 28 (2002) 106-176
86. Longman L.P., and Martin M.V. A practical guide to antibiotic prophylaxis in restorative dentistry. Dental Update 26 (1999) 7-14
87. Palmer N.A. Revisiting the role of dentists in prescribing antibiotics. Dental Update 30 (2003) 570-574
88. Samaranayake L.P. Antimicrobial chemotherapy. Essential microbiology for dentistry (2006), Churchill Livingstone Elsevier, Philadelphia, PA p. 67-76
89. Seymour R.A., and Whitworth J.M. Antibiotic prophylaxis for endocarditis, prosthetic joints, and surgery. Dental Clinics of North America 46 (2002) 635-651
90. Tong D.C., and Rothwell B.R. Antibiotic prophylaxis in dentistry: a review and practice recommendations. Journal of the American Dental Association 131 (2000) 366-374
91. Wilson W., Taubert K.A., Gewitz M., Lockhart P.B., Baddour L.M., Levison M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Journal of the American Dental Association 138 (2007) 739-45, 47-60
92. Prophylaxis against infective endocarditis guideline: consultation. The National Institute for Health and Clinical Excellence (NICE). http://www.nice.org.uk/guidance/index.jsp?action=folder&o=38144 [12 November 2007, date last accessed].
93. Krigar D.M., Kaltschmitt J., Krieger J.K., and Eickholz P. Two subgingival plaque-sampling strategies used with RNA probes. J Periodontol 78 (2007) 72-78
94. Horiba N., Yoshida T., Suzuki K., Maekawa Y., Ito M., Matsumoto T., et al. Isolation of methicillin-resistant staphylococci in the dental operatory. Journal of Endodontics 21 (1995) 21-25
95. Kurita H., Kurashina K., and Honda T. Nosocomial transmission of methicillin-resistant Staphylococcus aureus via the surfaces of the dental operatory. British Dental Journal 201 (2006) 297-300; discussion 291
96. Rautemaa R., Nordberg A., Wuolijoki-Saaristo K., and Meurman J.H. Bacterial aerosols in dental practice-a potential hospital infection problem?. The Journal of Hospital Infection 64 (2006) 76-81